Evidence map›Paper›PMID 35547797›Full record

ArticleActa crystallographica. Section E, Crystallographic communications2022

Crystal structures of six 4-(4-nitro-phenyl)-piperazin-1-ium salts.

Ninganayaka Mahesha, Haruvegowda Kiran Kumar, Hemmige S Yathirajan, Sabine Foro, Mohammed S M Abdelbaky, Santiago Garcia-Granda

Abstract read
In one paragraph

Article in Acta crystallographica. Section E, Crystallographic communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Syntheses and crystal structures of three salts of 1-(4-nitro-phenyl)-piperazine.Acta crystallographica. Section E, Crystallographic communications · 2023
    Article
  2. Syntheses, crystal structures and Hirshfeld surface analysis of three salts of 1-(4-nitro-phenyl)-piperazine.Acta crystallographica. Section E, Crystallographic communications · 2023
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ninganayaka MaheshaDepartment of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore-570 006, India.
Haruvegowda Kiran KumarDepartment of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore-570 006, India.ORCID https://orcid.org/0000-0002-9035-1458
Hemmige S YathirajanDepartment of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore-570 006, India.ORCID https://orcid.org/0000-0001-9039-0273
Sabine ForoInstitute of Materials Science, Darmstadt University of Technology, Alarich-Weiss-Strasse 2, D-64287 Darmstadt, Germany.ORCID https://orcid.org/0000-0001-8341-0205
Mohammed S M AbdelbakyDepartment of Physical and Analytical Chemistry, Faculty of Chemistry, Oviedo University-CINN, Oviedo 33006, Spain.
Santiago Garcia-GrandaDepartment of Physical and Analytical Chemistry, Faculty of Chemistry, Oviedo University-CINN, Oviedo 33006, Spain.ORCID https://orcid.org/0000-0002-2373-0247

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Six piperazinium salts, namely 4-(4-nitro-phenyl)-piperazin-1-ium 4-bromo-ben-zo-ate dihydrate, C

Indexed as

benzoate anionbiological activitycrystal structurepiperazine

Identifiers

PMID35547797
PMCPMC9069513

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.